Geographic Atrophy
Symptoms, Doctors, Treatments, Advances & More

Geographic Atrophy Overview

Save information for later
Sign Up

Learn About Geographic Atrophy

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Geographic Atrophy Local Doctors?
Elite in Geographic Atrophy
Ophthalmology | General Surgery
Elite in Geographic Atrophy
Ophthalmology | General Surgery

Duke Eye Center

2351 Erwin Rd, 
Durham, NC 
Experience:
39+ years
Languages Spoken:
English
Offers Telehealth

I’m a retina specialist who takes care of patients who have problems with the back of the eye. When a patient comes to see me, I like getting to know them and their history, so that I can tailor their treatment. My patients come from a variety of different backgrounds, so I find that I often learn as much from them as they do from me. Everybody has a different story and I very much like to learn about the patients to whom I provide care. Duke is a great place at which to work and from which to seek treatment because it’s a very collaborative institution. Everyone works together to do what’s best for the patient. Outside of work, I like to spend as much time as possible with my family. I also enjoy cooking, playing sports and watching sports. Dr. Jaffe is rated as an Elite provider by MediFind in the treatment of Geographic Atrophy. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal. Dr. Jaffe is board certified in American Board Of Ophthalmology, Ophthalmology.

Elite in Geographic Atrophy
Ophthalmology
Elite in Geographic Atrophy
Ophthalmology

Cleveland Clinic Main Campus

2022 East 105th Street, 
Cleveland, OH 
Experience:
38+ years
Languages Spoken:
English

Peter Kaiser is an Ophthalmologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 38 years. Dr. Kaiser is rated as an Elite provider by MediFind in the treatment of Geographic Atrophy. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Vitrectomy, and Osteotomy. Dr. Kaiser is board certified in American Board Of Ophthalmology, 1998.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Geographic Atrophy
Elite in Geographic Atrophy

Retina Vitreous Associates Of FL

4344 Central Avenue, 
St Petersburg, FL 
Languages Spoken:
English

David Eichenbaum is an Ophthalmologist practicing medicine in St Petersburg, Florida. Dr. Eichenbaum is rated as an Elite provider by MediFind in the treatment of Geographic Atrophy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Macular Edema (DME), and Vitrectomy. Dr. Eichenbaum is board certified in American Board Of Ophthalmology.

What are the latest Geographic Atrophy Clinical Trials?
Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy Under Everyday Conditions - a Multicentric, Randomized, Double-masked, Sham-controlled Pilot Study

Summary: Geographic atrophy (GA) is a progressive eye disease that causes the degeneration of the retinal cells, particularly in the macula, leading to vision loss. The goal of this pilot study is to evaluate the safety and the effectiveness of transcorneal electrical stimulation (TES) therapy with the OkuStim 2 System in patients with geographic atrophy (GA). Researchers will compare the effects of two di...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration (i-SIGHT2): a Multicentre, Randomised, Sham-controlled, Double-masked, Clinical Device Trial.

Summary: The goal of this clinical trial is to characterize the safety and effectiveness of the i-Lumen AMD transpalpebral microcurrent device and therapy in patients with intermediate to advanced nonexudative AMD. Participants will: * Undergo an initial loading regimen, followed by 7 maintenance over the course of 11 months. * Participants will return monthly through Month 14 (3 months post-last treatment...